China Independent Clinical Laboratory Industry Report, 2015-2018

Oct, 2015   |   100  Pages   |   ResearchInChina   |   Format : PDF
The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market size takes up 38%, 50%, and 67% of medical diagnostic markets of their own. Chinese independent clinical laboratory market size was around RMB4.73 billion in 2014, accounting for only 2%-3% of its own medical diagnostic market.

However, owing to large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory market size is expected to grow rapidly at a rate of 30%-40% over the next three to five years and reach RMB16.4 billion in 2018. Furthermore, affected by economic level, medical needs, and people's cognition, the Chinese independent clinical laboratory market is still concentrated in southeastern coastal areas and provincial capitals, such as Beijing, and Chengdu and Chongqing in Southwest China.

There are about 110 independent clinical laboratory enterprises in China, mainly comprehensive diagnostic chains and special diagnostic enterprises. KingMed Diagnostics, Dian Diagnostics, ADICON Clinical Laboratories, and DaAn Health (invested by Da An Gene), which hold a combined market share of 70%, all adopt chain-based model of comprehensive diagnostic services. By the end of 2014, the four enterprises separately had 27, 19, 15, and 8 indepen
1 Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2 Overview of Chinas Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Market
2.2.1 Status Quo
2.2.2 Analysis of Benchmarking Company
2.3 Development
2.4 Competitive Landscape

3 Upstream and Downstream of Chinas Independent Clinical Laboratory Industry
3.1 Upstream Market
3.1.1 Status Quo
3.1.2 Competitive Landscape
3.2 Downstream Market
3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
3.2.2 Healthcare Reform Boosts Rapid Development of Independent Clinical Laboratory Market
3.2.3 Demand Diversification Promotes Upgrading of Independent Clinical Laboratory Industry
3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster

4 Major Independent Clinical Laboratory Enterprises in China
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Independent Clinical Laboratory Business
4.1.3 Operation and Development
4.2 ADICON Clinical Laboratories, Inc
4.2.1 Profile
4.2.2 Independent Clinical Laboratory Business
4.2.3 Development
4.3 Zhejiang Dian Diagnostics Co., Ltd.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory Business
4.3.7 Customers and Suppliers
4.3.8 Forecast and Outlook
4.4 Da An Gene Co., Ltd. of Sun Yat-Sen University
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D and Investment
4.4.6 Independent Clinical Laboratory Business
4.4.7 Customers and Suppliers
4.4.8 Forecast and Outlook
4.5 Nymphavn Biotechnology Corporation Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Independent Clinical Laboratory Business
4.5.7 Forecast and Outlook
4.6 Surexam Biotechnology Co., Ltd.
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 Independent Clinical Laboratory Business
4.6.6 Forecast and Outlook
4.7 Ningbo Medicalsystem Biotechnology Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Independent Clinical Laboratory Business
4.7.7 Forecast and Outlook
4.8 Amoy Diagnostics Co., Ltd.
4.8.1 Profile
4.7.2 Independent Clinical Laboratory Business
4.9 CapitalBio
4.9.1 Profile
4.9.2 Independent Clinical Laboratory Business
4.10 Beijing Adinovo Gene Technology Co., Ltd.
4.10.1 Profile
4.10.2 Independent Clinical Laboratory Business
4.11 Kindstar Global
4.11.1 Profile
4.11.2 Independent Clinical Laboratory Business
4.12 Deyi Diagnostics
4.12.1 Profile
4.12.2 Independent Clinical Laboratory Business
4.13 Beijing IPE Biotechnology Co. Ltd
4.14 Shanghai Biotecan Pharmaceuticals Co., Ltd.

5 Prediction and Outlook
5.1 Industry Development
5.2 Operation Comparison among Enterprises
5.2.1 Revenue
5.2.2 Gross Margin
Sorry No Reports Matching to your search criteria

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Fax Number: +91 22 27812707

Follow Us On: